CollPlant Biotechnologies (CLGN) EBT Margin (2017 - 2026)
CollPlant Biotechnologies' EBT Margin was -4267.12% in the quarter ended Mar 30, 2026, down 4186.93 percentage points from -80.19% a year earlier but up 982.88 percentage points from the prior quarter.
CollPlant Biotechnologies (CLGN) EBT Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, CollPlant Biotechnologies' EBT Margin was -1695.12% through Mar 30, 2026, down 1462.19 percentage points year-over-year; for the year ended Dec 31, 2025, it was -468.28%, up 2738.12 percentage points from the prior year.
- EBT Margin shows a five-year change of -377.15 percentage points (years ended Dec 2020 to Dec 2025).
- In earlier years, EBT Margin was -3206.41% in the year ended Dec 31, 2024 (-3145.05 pp), -61.36% in the year ended Dec 31, 2023 (+5549.35 pp), -5610.70% in the year ended Dec 31, 2022 (-5612.52 pp) and 1.82% in the year ended Dec 31, 2021 (+92.95 pp).
- Quarterly EBT Margin has moved between -113550.00% (the quarter ended Sep 30, 2024) and 4417.35% (the quarter ended Mar 31, 2024) over five years.
- Compared with a year earlier, EBT Margin was higher in three of the last eight quarters, with an average year-over-year change of -546.50 percentage points.
- The best year-over-year quarter for EBT Margin over five years was the quarter ended Sep 30, 2025 (a gain of 108995.45 percentage points); the worst was the quarter ended Sep 30, 2024 (a drop of 102847.67 percentage points).
- Per Business Quant data, CLGN's EBT Margin in the three quarters before the quarter ended Mar 30, 2026 was -5250.00% (quarter ended Dec 31, 2025), -4554.55% (quarter ended Sep 30, 2025) and 1775.42% (quarter ended Jun 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | CollPlant Biotechnologies | 4.85 Mn | 4.85 Mn | -243,000.00 | -4,267.12% |
Historic Data
| Date | Value |
|---|---|
| Mar 30, 2026 | -4,267.12% |
| Dec 31, 2025 | -5,250.00% |
| Sep 30, 2025 | -4,554.55% |
| Jun 30, 2025 | 1,775.42% |
| Mar 30, 2025 | -80.19% |
| Dec 31, 2024 | -2,423.17% |
| Sep 30, 2024 | -113,550.00% |
| Jun 30, 2024 | 1,769.48% |
| Mar 31, 2024 | 4,417.35% |
| Dec 31, 2023 | -1,694.98% |
| Sep 30, 2023 | -10,702.33% |
| Jun 30, 2023 | 55.74% |
| Mar 31, 2023 | 812.70% |
| Dec 31, 2022 | -8,062.07% |
| Sep 30, 2022 | -4,099.08% |
| Jun 30, 2022 | -6,340.91% |
| Dec 31, 2021 | -1,217.42% |
| Sep 30, 2021 | -2,156.43% |
| Jun 30, 2021 | -431.69% |
| Mar 31, 2021 | 69.62% |
CollPlant Biotechnologies EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();